The phosphorylation of both PDK1 and 4E-BP1 was similarly inhibited by the three-drug combination, suggesting equivalent inhibitory effects of [Gem+Clo+Ed] on the AKT pathway in both T-cell and B-cell lymphoma cell lines. Here, PDK1 is linked to B-cell non-Hodgkin lymphoma.